title: Inhibition of growth and induction of differentiation of glioma cell lines by oncostatin M (OSM).
abstract: The neuropoietic cytokines of the interleukin-6 family are a group of structurally and functionally related polypeptides. We studied the effect of the multifunctional neuropoietic cytokines, including oncostatin M (OSM), leukemia inhibitory factor (LIF) and interleukin-6 (IL-6), on anaplastic glioma cell lines. Growth and morphology of the glioma cell lines were affected differently. While IL-6 and LIF exerted no or only small minor morphological changes and growth retardation, OSM induced a marked change in morphology and a strong suppression of growth. OSM treated cells were characterized by enlargement and the formation of multiple, thin processes thus resembling mature cultured astrocytes. The growth inhibitory effects were dose dependent with a maximum exerted by addition of 50 ng/ml OSM. The inhibition of DNA synthesis by OSM could be abolished by antibodies blocking either the activity of OSM or the OSM-receptor component, gp130.
authors.affiliation: Clinic of Neurology, Westf. Wilhelms-Universität Münster, Germany.
authors.forename: H
authors.initials: H
authors.lastname: Halfter
authors.forename: R
authors.initials: R
authors.lastname: Lotfi
authors.forename: R
authors.initials: R
authors.lastname: Westermann
authors.forename: P
authors.initials: P
authors.lastname: Young
authors.forename: E B
authors.initials: EB
authors.lastname: Ringelstein
authors.forename: F T
authors.initials: FT
authors.lastname: Stögbauer
mesh_terms: D000906:Antibodies / Q000276:immunology / Q000494:pharmacology; D001973:Bromodeoxyuridine / Q000378:metabolism; D002454:Cell Differentiation / Q000187:drug effects*; D002455:Cell Division / Q000187:drug effects*; D048429:Cell Size / Q000187:drug effects; D016207:Cytokines / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects*; D016762:Genes, fos / Q000235:genetics; D005910:Glioma / Q000473:pathology*; D006131:Growth Inhibitors / Q000494:pharmacology; D006801:Humans; D015850:Interleukin-6 / Q000494:pharmacology; D053605:Leukemia Inhibitory Factor; D008222:Lymphokines / Q000494:pharmacology; D053683:Oncostatin M; D010455:Peptides / Q000494:pharmacology*; D010766:Phosphorylation / Q000187:drug effects; D019000:Phosphotyrosine / Q000032:analysis; D014407:Tumor Cells, Cultured
chemical_list: D000906:Antibodies; D016207:Cytokines; D006131:Growth Inhibitors; D015850:Interleukin-6; C507837:LIF protein, human; D053605:Leukemia Inhibitory Factor; D008222:Lymphokines; C508351:OSM protein, human; D010455:Peptides; D053683:Oncostatin M; D019000:Phosphotyrosine; D004247:DNA; D001973:Bromodeoxyuridine